Loading

Astrogen

June 06, 2024
Company Presentation
CNS/Neurological
Company Presentation Theater 2
Astrogen was founded by a pediatric neurologist and develops treatments for neurological diseases based on small molecules. AST-001, the core pipeline, is a treatment for core symptoms of autism spectrum disorder that can be applied from age 2. AST-001 showed superior efficacy and safety in phase 2 clinical trials, and is currently in phase 3 clinical trials. Recently, it was designated as an orphan drug by the Korea MFDS. AST-003 has improved solubility, PK, and ease of administration compared to AST-001, and clinical trials are scheduled to be conducted in Australia and the US. Subsequent pipelines are indicated for various intractable neurological diseases ranging from Rett syndrome(AST-004) and ADHD(AST-031) to Parkinson's disease(AST-030) and glioblastoma(AST-035). Among them, AST-035 is a thalidomide-based molecular glue and has superior efficacy, safety, stability, PK, and BBB permeability compared to reference drugs. Astrogen plans to establish a US corporation this year.
Astrogen
Company Website: http://www.astrogen.co.kr
Lead Product in Development: AST-001, a treatment for core symptoms of autism spectrum disorder
Number Of Unlicensed Products (For Which You Are Seeking Partners): 5 products: (1) Autism spectrum disorder (AST-003, an improved version of AST-001), (2) Rett syndrome (AST-004), (3) ADHD (AST-031), (4) Parkinson's disease (AST-030) and (5) Glioblastoma (AST-035). AST-030 has the advantage of being expandable to idiopathic pulmonary fibrosis (IPF) and AST-031 to obstructive sleep apnea (OSA), both of which have significant unmet clinical needs.

Company HQ City

Daegu

Company HQ State

Gyeongsangbuk-do

Company HQ Country

Korea, Republic of

CEO/Top Company Official

Su-Kyeong Hwang

Development Phase of Primary Product

Phase III
Speakers
Su-Kyeong Hwang, MD
CEO
Astrogen
Back to Session List

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS